Dr. David C. Rice is a thoracic and cardiovascular surgeon and Professor in Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. His focus is on providing the best and most modern surgical care possible to patients with thoracic malignancies like pleural mesothelioma and lung cancer. As a thoracic surgeon, he
Dr. Charles B. Simone is a radiation oncologist and specialist in the use of proton and photon radiation therapy and photodynamic therapy at Memorial Sloan Kettering Cancer Center in New York City and the New York Proton Center, where he is Chief Medical Officer. Dr. Simone treats patients with malignant pleural mesothelioma, lung cancer, and
Dr. Erin A. Gillaspie is a thoracic surgeon. She is the Chief of Thoracic Surgery at Creighton University Medical Center in Omaha, Nebraska, where she provides advanced surgical treatment for patients diagnosed with malignant pleural mesothelioma, lung cancer, and other thoracic malignancies. Inspired to become a thoracic surgeon by her own grandfather’s diagnosis of malignant
Dr. Lorraine D. Cornwell is a thoracic and cardiothoracic surgeon at the Michael E. DeBakey VA Medical Center in Houston, Texas. Her practice is directed toward providing state-of-the-art thoracic oncologic and cardiac surgical services to the country’s military veterans diagnosed with an array of diseases and conditions, including asbestos-related lung cancer and malignant pleural mesothelioma.
Malignant mesothelioma is challenging for numerous reasons. Always fatal, mesothelioma remains latent for decades before appearing in an aggressive and fast-moving way. Making matters worse, the condition’s rarity limits scientists’ ability to test new treatments. To address this, Australian researchers have explored using pleural effusion samples from patients to create models called “organoids” on which
Dr. Christine Lau is a thoracic surgeon and the Chief of Surgery at the University of Maryland School of Medicine in Baltimore, Maryland, as well as the chief of surgery at the University of Maryland Medical Center. She is a nationally renowned thoracic and lung transplant surgeon who has significant experience in treating patients with
Dr. Robert C. Miller is a nationally recognized radiation oncologist and the Medical Director of the Maryland Proton Treatment Center in Baltimore, Maryland. He is also a Professor in the University of Maryland School of Medicine Department of Radiation Oncology. Dr. Miller has extensive experience in cancer care and using radiation therapy for the treatment
Dr. Pranshu Mohindra is a radiation oncologist at the University Hospitals Cleveland Medical Center in Cleveland, Ohio, where he serves as Professor and Vice-Chair of Operations and Quality for the Department of Radiation Oncology and the Director of the University Hospitals Proton Therapy Center. He is also a senior attending physician with the University Hospitals
Malignant mesothelioma is one of the most challenging diseases confronting modern medicine. The aggressive form of asbestos-related cancer has been resistant to traditional therapies, stymying researchers, frustrating physicians, and devastating patients and their families. A recent study examining variations in lung cancer microenvironments has yielded information that may provide new answers and avenues of exploration
Dr. Prakash Neupane is a medical oncologist at the University of Kansas Medical Center in Kansas City, where he specializes in the care of patients with head and neck cancers and thoracic cancers, including lung cancer and malignant pleural mesothelioma. In addition to his clinical role, he is a Professor of Medical Oncology, Program Director